# Divalproex sodium

NDC: 46708-821
Generic name: Divalproex sodium
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20241223

FDA application: ANDA218793

## Active ingredients

- DIVALPROEX SODIUM: 125 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-821"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-821
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f34c4504-5409-406e-995b-138e5f700242